Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Payables (2017 - 2025)

Historic Payables for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $973000.0.

  • Q32 Bio's Payables fell 2265.5% to $973000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $973000.0, marking a year-over-year decrease of 2265.5%. This contributed to the annual value of $3.0 million for FY2024, which is 1381.2% down from last year.
  • Q32 Bio's Payables amounted to $973000.0 in Q3 2025, which was down 2265.5% from $910000.0 recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's Payables registered a high of $9.9 million during Q1 2022, and its lowest value of $910000.0 during Q2 2025.
  • Over the past 5 years, Q32 Bio's median Payables value was $3.5 million (recorded in 2023), while the average stood at $3.7 million.
  • Its Payables has fluctuated over the past 5 years, first soared by 20314.69% in 2023, then tumbled by 8387.8% in 2024.
  • Q32 Bio's Payables (Quarter) stood at $2.4 million in 2021, then tumbled by 51.65% to $1.1 million in 2022, then soared by 203.15% to $3.5 million in 2023, then decreased by 13.81% to $3.0 million in 2024, then crashed by 67.45% to $973000.0 in 2025.
  • Its Payables stands at $973000.0 for Q3 2025, versus $910000.0 for Q2 2025 and $2.7 million for Q1 2025.